For Canadians seeking weight loss medications now, tirzepatide (Mounjaro/Zepbound) received Health Canada approval in 2024 and offers similar dual-receptor agonism
Semaglutide (Ozempic / Wegovy) Ozempic was originally approved to improve blood sugar control in adults with type 2 diabetes
Consult a healthcare provider before starting any weight loss medication
Two possible explanations for this effect are proposed: (1) reduced food intake due to an irritant effect of the treatment on the gastrointestinal tract (255, 256) or (2) a stimulant effect of TTFD on metabolism via enhanced noradrenaline secretion and thermogenesis (257)
Because a 4.5 mg dose uses almost the entire vial, plan vial supply accordingly
Even though GLP-1 medications suppress appetite, its important to consume adequate protein, vitamins, minerals, and overall calories to support your health